NetworkNewsBreaks – Cannabis Global Inc. (CBGL) Announces Filing of Patent for New Class of ‘Revolutionary’ Nano Cannabinoid
Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing unique infusion technologies and products, has filed a new patent application. The nonprovisional application is a direct result of CBGL’s Project Varin and expands on the technologies and developments contained in the company’s provisional applications filed on Nov. 4, 2019. This recent application outlines new methods for the manufacture of highly bioavailable and ultra-fast-acting cannabinoids for use in a variety of applications, including in beverages, food and topicals. Calling the technology “revolutionary,” the announcement notes that this patent may rewrite the efficacy and cost equations in the cannabis industry; the technology also provides for considerably faster onset of active cannabinoids ingredients, with the potential to reduce the time from hours to minutes. “We believe what we have created is highly significant to the cannabis industry, especially as nationwide cannabis legalization looms on the horizon,” Cannabis Global CEO Arman Tabatabaei said in the press release. “This new cannabinoid delivery system is designed to allow beverage, food and cosmetic product formulators to use significantly less cannabinoids in products while achieving similar or meaningfully greater efficacy. Our patent filing covers not only the new processes developed to create the new forms of cannabinoids but also the nanoparticles and nanofibers using the outlined processes and ingredients. We are especially proud of the fact we have been able to use food-grade ingredients in many of the formulations allowing consumer product companies to produce the clean labels consumers are increasingly desiring.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing unique infusion technologies and products, has filed a new patent application. The nonprovisional application is a direct result of CBGL’s Project Varin and expands on the technologies and developments contained in the company’s provisional applications filed on Nov. 4, 2019. This recent application outlines new methods for the manufacture of highly bioavailable and ultra-fast-acting cannabinoids for use in a variety of applications, including in beverages, food and topicals. Calling the technology “revolutionary,” the announcement notes that this patent may rewrite the efficacy and cost equations in the cannabis industry; the technology also provides for considerably faster onset of active cannabinoids ingredients, with the potential to reduce the time from hours to minutes. “We believe what we have created is highly significant to the cannabis industry, especially as nationwide cannabis legalization looms on the horizon,” Cannabis Global CEO Arman Tabatabaei said in the press release. “This new cannabinoid delivery system is designed to allow beverage, food and cosmetic product formulators to use significantly less cannabinoids in products while achieving similar or meaningfully greater efficacy. Our patent filing covers not only the new processes developed to create the new forms of cannabinoids but also the nanoparticles and nanofibers using the outlined processes and ingredients. We are especially proud of the fact we have been able to use food-grade ingredients in many of the formulations allowing consumer product companies to produce the clean labels consumers are increasingly desiring.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
